Primary care research into diabetes evolution (PRIDE)

Prospective study of the long-term outcomes of diabetes and its complications. [Primary care Research Into Diabetes Evolution (PRIDE)]

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN76746689

Enrollment

15000

Registered

2012-11-30

Start date

2012-01-18

Completion date

Unknown

Last updated

2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Sleep disorders Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

This is observational research and does not include any interventions. The study will be conducted in three phases. PRIDE 1: patients will be asked to complete a comp

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diabetes mellitus 2. Adults >18 years old 3. Men and women 4. Ability to give informed consent, and complete study

Exclusion criteria

Exclusion criteria: Current or concomitant illness that would interfere with the individual?s ability to perform the study or confound the study results. For PRIDE 2 and 3, type 1 diabetes patients will be excluded.

Design outcomes

Primary

Measure	Time frame
In PRIDE 1 a questionnaire booklet will be issued to all patients willing to take part. It contains the following measures: EQ5D, stanford presenteeism scale, Mental Health Inventory (MHI5), Problem Areas in Diabetes (PAID) score, International Physical Activity Questionnaire (IPAQ), Pittsburgh Sleep Quality Index (PSQI), Berlin Questionnaire, Epworth Sleepiness Scale (ESS), Food Frequency Questionnaire (FFQ) and some healthcare utilisation measures. The questionnaire also includes the following descriptive variables: age at diabetes diagnosis, ethnicity, marital status, education level, dependents, family history, employment, smoking status, alcohol intake, comorbidities, and whether someone has accessed online health information. Further descriptive data on the participants will be gathered from their GP records. These will include: height, weight, waist circumference, blood pressure, blood glucose. In PRIDE 2 the following additional measurements will be taken from those selected to be part of this phase: variety of medication intake, sleep duration, ApneaHypopnea Index (AHI), cortisol, renal impairment stage, physical activity level, diabetic neuropathy stage, amount of dietary intake, past weight, past waist and neck circumference, past blood pressure, past albumin creatinine ratio, coping strategies level, depression and anxiety level, locus of control, impulsivity and cognitive function, readiness to change and the Functional Outcomes of Sleep Questionnaire (FOSQ) score. In PRIDE 3 the main outcomes will be: patients? current priorities in their lives, patients? account of the impact of unemployment on selfmanagement, patients? account of the impact of diagnosis on selfesteem, identity, ?candidacy?, and stigma, patients? perceptions of risk regarding the complications of type 2 diabetes, patients? views and perspectives on sleep and patients? views, understanding and perceptions of current service provision, i	—

Measure

Time frame

In PRIDE 1 a questionnaire booklet will be issued to all patients willing to take part. It contains the following measures: EQ5D, stanford presenteeism scale, Mental Health Inventory (MHI5), Problem Areas in Diabetes (PAID) score, International Physical Activity Questionnaire (IPAQ), Pittsburgh Sleep Quality Index (PSQI), Berlin Questionnaire, Epworth Sleepiness Scale (ESS), Food Frequency Questionnaire (FFQ) and some healthcare utilisation measures. The questionnaire also includes the following descriptive variables: age at diabetes diagnosis, ethnicity, marital status, education level, dependents, family history, employment, smoking status, alcohol intake, comorbidities, and whether someone has accessed online health information. Further descriptive data on the participants will be gathered from their GP records. These will include: height, weight, waist circumference, blood pressure, blood glucose. In PRIDE 2 the following additional measurements will be taken from those selected to be part of this phase: variety of medication intake, sleep duration, ApneaHypopnea Index (AHI), cortisol, renal impairment stage, physical activity level, diabetic neuropathy stage, amount of dietary intake, past weight, past waist and neck circumference, past blood pressure, past albumin creatinine ratio, coping strategies level, depression and anxiety level, locus of control, impulsivity and cognitive function, readiness to change and the Functional Outcomes of Sleep Questionnaire (FOSQ) score. In PRIDE 3 the main outcomes will be: patients? current priorities in their lives, patients? account of the impact of unemployment on selfmanagement, patients? account of the impact of diagnosis on selfesteem, identity, ?candidacy?, and stigma, patients? perceptions of risk regarding the complications of type 2 diabetes, patients? views and perspectives on sleep and patients? views, understanding and perceptions of current service provision, i

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026